Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin QTc and Food Effect Study
NCT03362853Phase 1Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Jun 2012
- Primary completion
- Aug 2012
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial of nemonoxacin in community acquired pneumonia (CAP) and bacterial infection (4 arms), sponsored by TaiGen Biotechnology Co., Ltd. Primary endpoint: Baseline-adjusted mean QTcF at 2 days. Started Jun 2012; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)bacterial infection
Beyond the preview
Go deeper on NCT03362853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362853.